Diamines, A David amongst the Chemical Goliaths
Stock is spending some time near resistance level while support is being tested....
Diamines is quite an Illiquid stock and a small cap as well..their products are termed as speciality chemicals..company guides average long term EBITDA to be 30%
The company may have planned large scale capex being done through subsidary and associate co. However, I cannot substantiate actual numbers. There is concentration in the holding amongst minority shareholders which is some 14,000 minority shareholders only, mostly individuals.
Stop loss for the trade will be closing below 50 weeks EMA, can whipsaw as well as had done before. So if one is entering then there is need to monitor and determine support at the 50WEMA
Target is 890-900.. trade idea based on
- stock at support area
- weekly macd histogram supports going long for maximizing positional gains, maybe 2-3 weeks earlier entry done
- chart pattern forming a cup then another with a lower depth and one more at similar levels while support is rising as can be seen from the trendline
Diamines is quite an Illiquid stock and a small cap as well..their products are termed as speciality chemicals..company guides average long term EBITDA to be 30%
The company may have planned large scale capex being done through subsidary and associate co. However, I cannot substantiate actual numbers. There is concentration in the holding amongst minority shareholders which is some 14,000 minority shareholders only, mostly individuals.
Stop loss for the trade will be closing below 50 weeks EMA, can whipsaw as well as had done before. So if one is entering then there is need to monitor and determine support at the 50WEMA
Target is 890-900.. trade idea based on
- stock at support area
- weekly macd histogram supports going long for maximizing positional gains, maybe 2-3 weeks earlier entry done
- chart pattern forming a cup then another with a lower depth and one more at similar levels while support is rising as can be seen from the trendline
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。